SCBIO Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SCBIO Inc. - overview
Established
2021
Location
Daejeon, -, South Korea
Primary Industry
Biotechnology
About
Founded in 2021, and based in Daejeon, South Korea, SCBIO Inc. operates as a biotechnology company that is involved in the research on cancer-related diseases with the goal of developing anticancer drugs. In August 2022, SCBIO Inc. raised KRW 6 billion in Pre-Series A funding from Magna Investments, L&S Venture Capital, Korea University Technology Holdings, Korea Technology Finance Corporation, etc.
In May 2023, SCBIO Inc. raised KRW 11 billion in series A funding from new investors T. S. Investment, LSK Investment, Industrial Bank of Korea, Holistic Growth Initiative, Daesung Startup Investment, and A Ventures, with participation from returning investors Magna Investments, L&S Venture Capital, and Korea Science & Technology Holdings.
also participated in this round. As of August 2022, the firm is being led by Lee Chang-hoon as its CEO and employs over 20 professionals. The firm develops low-molecular compound immunotherapy drugs namely SCB001 and SCB002 that regulate immune cell activity in tumors to produce anti-cancer efficacy, and is especially helpful in treating pancreatic cancer. The company intends to use the August 2022 funding to continue the research and development of its lead projects, 'SCB001' and 'SCB002'.
The company will use the May funding to spur preclinical trials for SCB002 and SCB001, and clinical development costs for IND approval.
Current Investors
L&S Venture Capital, Magna Investment, Daedeok Venture Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.sc-bio.co.kr
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.